🟢 Veradermics is trading 4.48% up in pre-market with no clear overnight catalyst

Veradermics is trading at $145.00, up 4.48%, with no clear overnight catalyst identified for October 26.

• Shares are above the October 23 close of $138.78.
• Positive Phase 3 results reported October 19 and an October 22 analyst price-target increase are earlier developments, not confirmed explanations for the pre-market move.
• The supplied market context is modestly positive but does not establish a broad-market cause.